Carson P, Lyons M
Slievemore Clinic, Dublin, Ireland
Edinburgh Medical School, Scotland
Ir Med J. 2019 Feb 14;112(2):874.
Aim Report successful application of UV endonasal phototherapy as a treatment for severe rhinitis medicamentosa and allergic rhinitis. Methods Allergic rhinitis confirmed by history and skin prick testing; rhinitis medicamentosa based on history. Both confirmed at nasendoscopy. Symptom score before & after treatment. Introduction of Rhinolight endonasal u/v phototherapy for allergic rhinitis. Single patient report. Results Successful remission of Rhinitis Medicamentosa confirmed with patient after eight sessions Rhinolight endonasal phototherapy. Use of nasal decongestant dropped from 2 bottles/daily x 4 years to zero. Symptoms reduced from 25 pre-treatment to 6 post-treatment. Rhinitis medicamentosa is clinically characterized by nasal congestion without rhinorrhea, postnasal drip, or sneezing that begins after using a nasal decongestant for more than 3 days. Treatment involves discontinuation of the offending drug. Discussion Rhinolight endonasal phototherapy is a new treatment for allergic rhinitis and offered as last resort for a patient with untreated allergic rhinitis and overuse of topical decongestants. Patient reports a significant improvement in symptoms with cessation of topical decongestant. Report a successful application of UV endonasal phototherapy as a treatment for severe rhinitis medicamentosa against a background of long standing allergic rhinitis.
目的 报告鼻内紫外线光疗成功应用于治疗重度药物性鼻炎和过敏性鼻炎。方法 通过病史和皮肤点刺试验确诊过敏性鼻炎；根据病史确诊药物性鼻炎。两者均经鼻内镜检查确认。记录治疗前后的症状评分。介绍用于过敏性鼻炎的鼻内Rhinolight紫外线光疗。单病例报告。结果 经8次鼻内Rhinolight光疗后，患者的药物性鼻炎成功缓解。鼻用减充血剂的使用从每日2瓶×4年降至零。症状从治疗前的25分降至治疗后的6分。药物性鼻炎的临床特征为在使用鼻用减充血剂超过3天后出现鼻塞，无流涕、鼻后滴漏或打喷嚏。治疗包括停用致病药物。讨论 鼻内Rhinolight光疗是治疗过敏性鼻炎的一种新方法，是为患有未经治疗的过敏性鼻炎且过度使用局部减充血剂的患者提供的最后手段。患者报告症状有显著改善，且停用了局部减充血剂。报告鼻内紫外线光疗成功应用于治疗在长期过敏性鼻炎背景下的重度药物性鼻炎。
